Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta June 11, 2017 Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition December 12, 2017 Omeros To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 March 9, 2017
Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition December 12, 2017
Omeros To Announce Fourth Quarter And Year-End 2016 Financial Results On March 16, 2017 March 9, 2017
